Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 92337R101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Kynam Capital Management, LP
13G/A
Amendment 1
|
4.0% |
8/14/2026
Event 6/30/2026
|
|
| Kynam Capital Management, LP | 4.0% | ||
| Kynam Capital Management GP, LLC | 4.0% | ||
| Yue Tang | 4.0% | ||
| State Street Corp 13G | 5.8% |
8/7/2026
Event 6/30/2026
|
|
| BlackRock, Inc. 13G/A Amendment 1 | 7.4% |
7/30/2026
Event 6/30/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 3 | 6.4% |
5/15/2026
Event 3/31/2026
|
|
|
Point72 Asset Management, L.P.
13G
|
1.7% |
4/1/2026
Event 3/25/2026
|
|
| Point72 Asset Management, L.P. | 1.7% | ||
| Point72 Capital Advisors, Inc. | 1.7% | ||
| Steven A. Cohen | 1.7% | ||
| Vanguard Group Inc 13G/A Amendment 1 | 0% |
3/27/2026
Event 3/13/2026
|
|
|
Deep Track Capital, LP
13G
|
5.5% |
3/11/2026
Event 3/4/2026
|
|
| Deep Track Capital, LP | 5.5% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 5.5% | ||
| David Kroin | 5.5% | ||
|
Sofinnova Venture Partners X, L.P.
13D/A
Amendment 5
|
4.0% |
3/5/2026
Event 12/10/2025
|
|
| Sofinnova Venture Partners X, L.P. ("SVP X") | 3.9% | ||
| Sofinnova Management X, L.P. ("SM X LP") | 3.9% | ||
| Sofinnova Management X-A, L.L.C. ("SM X LLC") | 3.9% | ||
| Dr. James I. Healy ("Healy") | 3.9% | ||
| Dr. Maha Katabi ("Katabi") | 4.0% | ||
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 | 7.7% |
2/17/2026
Event 12/31/2025
|
|
|
FMR LLC
13G/A
Amendment 6
|
4.1% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 4.1% | ||
| Abigail P. Johnson | 4.1% | ||
| Vanguard Group Inc 13G | 5.0% |
1/30/2026
Event 12/31/2025
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 | 5.7% |
11/14/2025
Event 9/30/2025
|
|
|
Kynam Capital Management, LP
13G
|
5.4% |
8/14/2025
Event 6/30/2025
|
|
| Kynam Capital Management, LP | 5.4% | ||
| Kynam Capital Management GP, LLC | 5.4% | ||
| Yue Tang | 5.4% | ||
|
James E. Flynn
13G
|
5.3% |
6/11/2025
Event 6/6/2025
|
|
| Deerfield Mgmt, L.P. | 5.3% | ||
| Deerfield Management Company, L.P. | 5.3% | ||
| Deerfield Partners, L.P. | 5.3% | ||
| James E. Flynn | 5.3% | ||
|
Avoro Capital Advisors LLC
13G/A
Amendment 1
|
8.9% |
2/14/2025
Event 12/31/2024
|
|
| Avoro Capital Advisors LLC | 8.9% | ||
| Behzad Aghazadeh | 8.9% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 6 | 77.0 k | $2.49 M |
| 2026 Q2 | 234 | 80.0 M | $3.39 B |
| 2026 Q1 | 242 | 72.2 M | $2.92 B |
| 2025 Q4 | 228 | 74.0 M | $3.75 B |
| 2025 Q3 | 186 | 65.2 M | $1.89 B |
| 2025 Q2 | 190 | 63.9 M | $1.51 B |
| 2025 Q1 | 192 | 63.7 M | $1.54 B |
| 2024 Q4 | 188 | 62.9 M | $2.66 B |
| 2024 Q3 | 183 | 53.6 M | $2.37 B |
| 2024 Q2 | 186 | 54.9 M | $1.99 B |
| 2024 Q1 | 178 | 54.9 M | $2.37 B |
| 2023 Q4 | 104 | 43.5 M | $669 M |
| 2023 Q3 | 88 | 39.3 M | $538 M |
| 2023 Q2 | 86 | 38.1 M | $612 M |
| 2023 Q1 | 75 | 37.4 M | $290 M |
| 2022 Q4 | 61 | 21.6 M | $418 M |
| 2022 Q3 | 56 | 21.5 M | $459 M |
| 2022 Q2 | 52 | 20.4 M | $278 M |
| 2022 Q1 | 51 | 19.7 M | $469 M |
| 2021 Q4 | 38 | 14.1 M | $375 M |
| 2021 Q3 | 32 | 14.7 M | $252 M |
| 2021 Q2 | 23 | 14.5 M | $186 M |